Physician profile
Steven Lamm
NPI 1992856702
$5,618.48
in general payments reported to CMS, 2019-2025
18 companies · $2,042 in 2025
The $2,042 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $112 · 2021: $574 · 2022: $728 · 2023: $639 · 2024: $740 · 2025: $2,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,012 · Consulting Fee: $1,395 · Education: $14.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,011.50 |
| Consulting Fee | $1,395.00 |
| Education | $14.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,658.87 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Inspiremd LTD | $879.39 | 2021-2025 | Cguard Prime Carotid Stent System, Cguard, Cguard |
| Alkermes, INC. | $229.73 | 2019-2025 | Vivitrol, Vivitrol |
| Gilead Sciences, INC. | $198.34 | 2019 | |
| Lilly USA, LLC | $151.05 | 2019-2025 | Zepbound |
| Astellas Pharma US INC | $99.10 | 2019 | |
| Eisai INC. | $76.38 | 2019-2025 | |
| Halozyme INC | $45.75 | 2023 | |
| Allergan, INC. | $45.24 | 2019 | |
| Antares Pharma, INC. | $43.69 | 2019 | |
| Pfizer INC. | $34.00 | 2020-2021 | |
| Itamar Medical INC | $33.96 | 2022 | |
| Amgen INC. | $29.99 | 2019 | |
| Biobeat USA INC. | $26.03 | 2024 | Bb-613 Bpm Kit |
| Shire North American Group INC | $24.91 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.53 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.34 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lamm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.